|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/22 | |||
| C07K 16/30 | |||
| C07K 16/40 |
| (11) | Number of the document | 2370467 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09740078.2 |
| Date of filing the European patent application | 2009-10-01 | |
| (97) | Date of publication of the European application | 2011-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/062792 |
| Date | 2009-10-01 |
| (87) | Number | WO 2010/037835 |
| Date | 2010-04-08 |
| (30) | Number | Date | Country code |
| 101850 P | 2008-10-01 | US | |
| 101853 P | 2008-10-01 | US | |
| 101846 P | 2008-10-01 | US | |
| 101844 P | 2008-10-01 | US | |
| 101927 P | 2008-10-01 | US | |
| 101921 P | 2008-10-01 | US | |
| 101933 P | 2008-10-01 | US |
| (72) |
KUFER, Peter, DE
RAUM, Tobias, DE
KISCHEL, Roman, DE
LUTTERBÜSE, Ralf, DE
HOFFMANN, Patrick, DE
RAU, Doris, DE
KLINGER, Matthias, DE
MANGOLD, Susanne, DE
BLÜMEL, Claudia, DE
|
| (73) |
Amgen Research (Munich) GmbH,
Staffelseestrasse 2, 81477 München,
DE
|
| (54) | CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXC D3, IGF-1RXCD3 OR FAPALPHA XCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |
| CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXC D3, IGF-1RXCD3 OR FAPALPHA XCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |